Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Dopamine transporter genotype and stimulant dose-response in youth with attention-deficit/hyperactivity disorder.

Journal of child and adolescent psychopharmacology - 1 Jun 2014

Stein Mark A, Waldman Irwin, Newcorn Jeffrey, Bishop Jeffrey, Kittles Rick, Cook Edwin H

Abstract excerpt

OBJECTIVES: This study seeks to determine if variation in the dopamine transporter gene (SLC6A3/DAT1) moderates the dose-response effects of long-acting dexmethylphenidate (D-MPH) and mixed amphetamine salts (MAS) in children with attention-deficit/hyperactivity disorder (ADHD). METHODS: Fifty-six children and adolescents (mean age=11.7±2.2) participated in a double-blind, two period crossover, dose-response...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Attention Deficit Disorder with Hyperactivity

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Central Nervous System Stimulants

Share to Cross-Over Studies

Share to Dopamine Plasma Membrane Transport Proteins

Share to Dose-Response Relationship, Drug

Share to Double-Blind Method

Source

Open in PubMed Open full text

Identifiers

PMID: 24813374
DOI: 10.1089/cap.2013.0102
PMCID: PMC4064733

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Dopamine transporter genotype and stimulant dose-response in youth with attention-deficit/hyperactivity disorder.PMID 24813374Read ↗

Dopamine transporter genotype and methylphenidate dose response in children with ADHD.Semantic proximity Read ↗

Dopamine Transporter and CYP2D6 Gene Relationships with Attention-Deficit/Hyperactivity Disorder Treatment Response in the Methylphenidate and Atomoxetine Crossover Study.Semantic proximity Read ↗

Dopamine-related genotypes and the dose-response effect of methylphenidate on eating in attention-deficit/hyperactivity disorder youths.Semantic proximity Read ↗

Pharmacogenetic predictors of methylphenidate dose-response in attention-deficit/hyperactivity disorder.Semantic proximity Read ↗

Dopamine transporter genotype and stimulant side effect factors in youth diagnosed with attention-deficit/hyperactivity disorder.Semantic proximity Read ↗

DRD4 exon 3 genotype and ADHD: Randomised pharmacodynamic investigation of treatment response to methylphenidate.Semantic proximity Read ↗

Dopamine transporter genotype influences the physiological response to medication in ADHD.Semantic proximity Read ↗

Pharmacogenetics of methylphenidate response and tolerability in attention-deficit/hyperactivity disorder.Semantic proximity Read ↗

Dopamine transporter 3'-UTR VNTR genotype and ADHD: a pharmaco-behavioural genetic study with methylphenidate.Semantic proximity Read ↗

Response to methylphenidate in adults with ADHD is associated with a polymorphism in SLC6A3 (DAT1).Semantic proximity Read ↗

Dopamine transporter gene and response to methylphenidate in attention-deficit/hyperactivity disorder.Semantic proximity Read ↗

Dopamine transporter gene associated with diminished subjective response to amphetamine.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.